Cannabis Bioscience International Holdings, Inc.
CBIHDrugs in Pipeline
13
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Cannabidiol oral solution
Early Psychosis
THC/CBD
Back Pain
Cannabidiol (246mg press pill)
Memory
Full-spectrum CBD oil 100 mg/mL
Major Depressive Disorder (MDD)
Mild dose cannabis
Neuropathic Pain
THC Cannabis
HIV
Epidiolex
Autism
Experimental: Full-spectrum CBG oil 30 mg/mL
Attention-Deficit/Hyperactivity Disorder (ADHD)
CBD/THC
Essential Tremor
Psilocybin combined with Psychotherapy
Cannabis Use Disorder, Moderate
THC
THC
Cannabidiol (CBD) 800 mg
Tobacco Use Disorder
Cannabis
Fibromyalgia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Cannabidiol oral solution | Phase 3 | Early Psychosis | - | - |
THC/CBD | Phase 3 | Back Pain | - | - |
Cannabidiol (246mg press pill) | Phase 2 | Memory | - | - |
Full-spectrum CBD oil 100 mg/mL | Phase 2 | Major Depressive Disorder (MDD) | - | - |
Mild dose cannabis | Phase 2 | Neuropathic Pain | - | - |
THC Cannabis | Phase 2 | HIV | - | - |
Epidiolex | Phase 2 | Autism | - | - |
Experimental: Full-spectrum CBG oil 30 mg/mL | Phase 2 | Attention-Deficit/Hyperactivity Disorder (ADHD) | - | - |
CBD/THC | Phase 2 | Essential Tremor | - | - |
Psilocybin combined with Psychotherapy | Phase 2 | Cannabis Use Disorder, Moderate | - | - |
THC | Phase 2 | THC | - | - |
Cannabidiol (CBD) 800 mg | Phase 2 | Tobacco Use Disorder | - | - |
Cannabis | Phase 2 | Fibromyalgia | - | - |
Frequently asked questions
What is in Cannabis Bioscience International Holdings, Inc.'s drug pipeline?→
CatalystAlert tracks 13 drug candidates in Cannabis Bioscience International Holdings, Inc.'s (CBIH) pipeline across Phase 3, Phase 2. Its lead program is Cannabidiol oral solution (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Cannabis Bioscience International Holdings, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Cannabis Bioscience International Holdings, Inc. (CBIH) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CBIH biotech catalysts?→
Add CBIH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Cannabis Bioscience International Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.